ArticleTranslational lung cancer research2022

Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring

Guanghui Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.